NCT03802617View on ClinicalTrials.gov

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

PHASE2CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

October 22, 2019

Study Completion Date

October 22, 2019

Conditions
Uremic Pruritus
Interventions
DRUG

MR13A9

Intravenous administration

DRUG

Placebo

Intravenous administration

Trial Locations (1)

Unknown

Research Site, Multiple Locations

Sponsors

Collaborators (1)

Maruishi Pharmaceutical
All Listed Sponsors
collaborator

Maruishi Pharmaceutical

INDUSTRY

lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY